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Abstract
Background: The bacterial endosymbiont Wolbachia pipientis has been shown to increase host resistance to viral infection
in native Drosophila hosts and in the normally Wolbachia-free heterologous host Aedes aegypti when infected by Wolbachia
from Drosophila melanogaster or Aedes albopictus. Wolbachia infection has not yet been demonstrated to increase viral
resistance in a native Wolbachia-mosquito host system.
Methodology/Principal Findings: In this study, we investigated Wolbachia-induced resistance to West Nile virus (WNV;
Flaviviridae) by measuring infection susceptibility in Wolbachia-infected and Wolbachia-free D. melanogaster and Culex
quinquefasciatus, a natural mosquito vector of WNV. Wolbachia infection of D. melanogaster induces strong resistance to
WNV infection. Wolbachia-infected flies had a 500-fold higher ID50 for WNV and produced 100,000-fold lower virus titers
compared to flies lacking Wolbachia. The resistance phenotype was transmitted as a maternal, cytoplasmic factor and was
fully reverted in flies cured of Wolbachia. Wolbachia infection had much less effect on the susceptibility of D. melanogaster
to Chikungunya (Togaviridae) and La Crosse (Bunyaviridae) viruses. Wolbachia also induces resistance to WNV infection in Cx.
quinquefasciatus. While Wolbachia had no effect on the overall rate of peroral infection by WNV, Wolbachia-infected
mosquitoes produced lower virus titers and had 2 to 3-fold lower rates of virus transmission compared to mosquitoes
lacking Wolbachia.
Conclusions/Significance: This is the first demonstration that Wolbachia can increase resistance to arbovirus infection
resulting in decreased virus transmission in a native Wolbachia-mosquito system. The results suggest that Wolbachia
reduces vector competence in Cx. quinquefasciatus, and potentially in other Wolbachia-infected mosquito vectors.
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Introduction
Wolbachia pipientis is an intracellular, a-proteobacterial symbiont
that infects a wide variety of invertebrates, including insects,
spiders, mites, isopod crustaceans, and filarial nematodes
[1,2,3,4,5]. It was first identified in the mosquito Culex pipiens
and has been most studied for the broad range of reproductive
phenotypes that it induces in its various hosts, including
cytoplasmic incompatibility, feminization, parthenogenesis, and
male killing [6,7]. These reproductive phenotypes help to ensure
the bacterium’s persistence in the host population and have made
Wolbachia a highly successful symbiont, infecting up to 66% of
arthropod species [8,9].
Wolbachiahasbeenshowntoinfectatleast19speciesoffruitfliesof
the genus Drosophila [10,11,12,13,14]. In some species, like D.
simulans, Wolbachia causes robust and complex patterns of cytoplas-
mic incompatibility, while in other species, like D. melanogaster,
reproductive phenotypes are generally weak or absent
[14,15,16,17,18,19,20,21,22]. Despite the lack of a strong repro-
ductive phenotype, Wolbachia infection of D. melanogaster is nonethe-
less widespread [18,22,23,24]. This paradox suggests that non-
reproductive phenotypes probably confer a fitness advantage to
Wolbachia-infected D. melanogaster, thereby explaining the observed
persistence of Wolbachia infection. A variety of non-reproductive
phenotypeshaveadditionallybeenidentified in Wolbachia-infected D.
melanogaster, including effects on behavior, viability, insulin signaling,
and iron homeostasis [25,26,27,28,29,30,31,32,33]. While the
magnitude of most of these Wolbachia-dependent phenotypes is
generally modest and frequently variable, some of these could,
nonetheless, provide Wolbachia-infected flies with a selective fitness
advantage [32,33,34].
Wolbachia infection of D. melanogaster has also been shown to
increase the fly’s resistance to some viral infections, resulting in
infections with lower virus titers and less associated pathology
[35,36]. The resistance phenotype appears to be limited to RNA
viruses, with the strength of resistance varying substantially among
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by Drosophila C virus or cricket paralysis virus (DCV and CrPV;
Dicistroviridae) is strongly suppressed by Wolbachia infection with
titers of DCV being reduced up to 10,000-fold [35,36]. In
contrast, infection by Flock House virus (FHV; Nodaviridae) is not
inhibited by Wolbachia at the level of virus replication, yet the
pathology associated with FHV infection is strongly reduced [35].
For natural viral infections of D. melanogaster that cause pathology,
such as DCV, resistance to viral infection would clearly confer
Wolbachia-infected D. melanogaster a significant fitness advantage in
the face of viral infection.
Wolbachia from D. melanogaster can also confer resistance to viral
infection in a heterologous host. Wolbachia strain wMelPop, which
normally infects D. melanogaster, lacks normal replication control,
resulting in significant pathology and a shortened lifespan in the fly
[37]. Infection of the normally Wolbachia-free mosquito Aedes aegypti
with a mosquito-adapted strain of wMelPop produces mosquitoes
with both a shortened lifespan and increased resistance to viral
infection [38,39]. In addition, infection of Ae. aegypti with Wolbachia
from Aedes albopictus also increases viral resistance [40]. These
results clearly demonstrate that Wolbachia can increase viral
resistance when infecting a heterologous mosquito host. It is less
clear, however, whether Wolbachia ever increases viral resistance
when infecting their native mosquito hosts. To date, this question
has only been addressed in Ae. albopictus, and no increase in
susceptibility to dengue virus (DENV; Flaviviridae) or Chikungunya
virus (CHIKV; Togaviridae) infection was observed in Ae. albopictus
mosquitoes cured of their normal Wolbachia symbionts, suggesting
that Wolbachia infection does not increase viral resistance in this
native Wolbachia-mosquito system [40,41].
To investigate this question further, we looked for Wolbachia-
induced increases in resistance to infection by West Nile virus
(WNV; Flaviviridae)i nD. melanogaster and in the southern house
mosquito Culex quinquefasciatus, a natural vector of WNV. In both
cases, we looked for viral resistance induced by the Wolbachia strain
that naturally infects each species. We demonstrate that Wolbachia
infection of D. melanogaster increases resistance to infection by
WNV and that this protective effect is relatively specific to WNV
compared to other arboviruses. We further demonstrate that
Wolbachia also increases resistance to WNV infection in the
mosquito Cx. quinquefasciatus. While more modest than the level of
resistance observed in flies, the resistance phenotype in Cx.
quinquefasciatus was sufficient to significantly reduce the proportion
of infected mosquitoes that transmitted virus during feeding.
Results
Wolbachia increases resistance to WNV infection in
D. melanogaster
Our previous studies have shown that mutations in the RNAi
pathway of D. melanogaster increase susceptibility of flies to infection
by WNV [42]. During the course of these earlier studies, we
unexpectedly discovered that RNAi mutant strain Ago2
414 had the
opposite phenotype, being highly resistant to WNV infection (Fig.
S1; Text S1). Further genetic analysis determined that the
resistance phenotype was caused by a dominant, maternally
transmitted, cytoplasmic factor and not the nuclear genotype of
Ago2
414 flies (Figs. S2 and S3; Text S1). Maternal cytoplasmic
transmission of the phenotype combined with the known ability of
the bacterial endosymbiont Wolbachia pipientis to induce resistance
to viral infection in flies implicated Wolbachia as the cause of the
WNV resistance phenotype [35,36]. We directly tested this
hypothesis and found that the Ago2
414 flies were, in fact, infected
with Wolbachia (Fig. S4; Text S1) and that curing the flies of
Wolbachia infection reverted the resistance phenotype, producing
flies fully susceptible to WNV infection (Fig. S5; Text S1). These
results strongly support the conclusion that Wolbachia infection
causes the WNV resistance phenotype seen in the Ago2
414 flies.
To assess whether resistance to WNV infection is a general
phenotype of Wolbachia-infected D. melanogaster and not a
phenotype unique to the Ago2
414 mutant strain, we measured
susceptibility to WNV infection in BER1 flies, a wild type strain of
flies naturally infected with Wolbachia, and in tetracycline-treated
BER1-T flies cured of Wolbachia infection (Fig. 1). Wolbachia(+)
BER1 flies were found to be resistant to infection, with an ID50 for
WNV of 4190 plaque forming units (pfu) and low titers of virus in
infected flies (Fig. 2). In contrast, Wolbachia(-) BER1-T flies were
susceptible to infection, with an ID50 for WNV of 1.5 pfu and
consistently high titers of virus in all infected flies (Fig. 2). The
results for the BER1 flies paralleled what was observed for the
Ago2
414 flies (cf. Figs. 2 and S5), suggesting that resistance to WNV
infection is a general feature of Wolbachia-infected D. melanogaster.
To address the possibility that tetracycline treatment itself
caused the observed increase in WNV susceptibility independent
of the loss of Wolbachia infection, we treated wild-type Oregon R
flies (OR), which are not infected with Wolbachia (Fig. 1), with
tetracycline, and then compared WNV susceptibility in untreated
OR and tetracycline-treated OR-T flies (Fig. 3). In contrast to the
dramatically higher susceptibility observed for tetracycline-treated
BER1-T flies, tetracycline treatment of OR flies actually reduced
susceptibility (Fig. 3). Their ID50 values were 0.5 versus 0.7 for OR
and OR-T flies, respectively, and virus titers in the OR-T flies
were 1.7-fold lower when averaged across all the virus titers tested
(Fig. 3; p,0.001, t-test). Thus, tetracycline treatment itself does not
cause increased viral susceptibility, supporting the conclusion that
it is the loss of Wolbachia that is responsible for the observed
increase in WNV susceptibility.
WNV is more sensitive to Wolbachia-induced resistance
than CHIKV or LACV
Mosquito-vectored arboviruses that cause human zoonotic
disease include viruses from the Flaviviridae (including WNV),
Togaviridae, and Bunyaviridae families. To assess the relative strength
of Wolbachia-induced viral resistance against representative Toga-
viridae and Bunyaviridae viruses, we compared the susceptibility of
BER1 and BER1-T flies to infection with Chikungunya virus
(CHIKV; Togaviridae) and La Crosse virus (LACV; Bunyaviridae).
CHIKV proliferates robustly after inoculation into D. melanogaster
(Fig. 4). The ID50 for CHIKV in Wolbachia(+) BER1 flies was
Figure 1. Wolbachia status of D. melanogaster and Cx. quinque-
fasciatus strains analyzed for susceptibility to arbovirus
infection. DNA was isolated from D. melanogaster strains Oregon R
(OR) and BER1, and from Cx. quinquefasciatus (Cxq). Tetracycline-treated
strains lacking Wolbachia sequences are indicated by the suffix -T. DNA
sequences corresponding to the wsp gene of Wolbachia and the 12S
mitochondrial gene were identified by PCR.
doi:10.1371/journal.pone.0011977.g001
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various concentrations of CHIKV inoculated ranged from 6.4 to
9.1 log10 pfu/animal (Fig. 4). Wolbachia(2) BER1-T flies were
more susceptible to CHIKV infection than were the BER1 flies.
The ID50 for the BERT1-T flies was 3.6 pfu, 8-fold lower than
that for BER1 flies, and the average titer of virus in infected
BER1-T flies was higher at every concentration of virus tested,
averaging 4.2-fold higher when calculated across all inoculation
doses combined (p,1610
27, t-test). Thus, CHIKV infection of
BER1 flies is inhibited by Wolbachia, but the effect is weaker than
observed for WNV; specifically, the ID50 decreased by 8-fold
(CHIKV) versus 2793-fold (WNV) and the virus titer increased by
4.2-fold (CHIKV) versus 918-fold (WNV) when averaged across
all infected animals (cf. Figs. 2 and 4).
LACV replicates much less robustly in D. melanogaster than does
either WNV or CHIKV (Fig. 5). The low infectivity of LACV in
flies was anticipated. Tahyna virus has been shown previously to
be able to infect tissue culture cells of D. melanogaster, producing a
persistent infection, but releasing significantly less virus than cells
infected with WNV or CHIKV [43]. Because Tahyna virus and
LACV are both strains of California encephalitis virus, we could
anticipate that the two viruses would behave comparably in D.
melanogaster. The ID50 for LACV in Wolbachia(+) BER1 flies was
30 pfu, and the average titer of virus in infected animals ranged
from 1.5 to 3 log10 pfu/animal for the various concentrations of
LACV that were inoculated (Fig. 5). At the lower titers of
inoculum, more virus was produced during infection than was
injected, supporting the conclusion that LACV does cause low
levels of infection in flies, comparable to what has been reported
for tissue culture cells [43]. In contrast to the results found for
WNV and CHIKV, susceptibility to LACV was essentially
unchanged between Wolbachia(+) BER1 and Wolbachia(2) BER1-
T flies. The ID50 for the latter was 32 pfu, and the average titer of
virus in infected animals for the various concentrations of LACV
tested was not significantly different from the titer determined in
Wolbachia(+) BER1 flies (Fig. 5). The limited extent of the infection
caused by LACV does not allow us to draw strong conclusions
from these data, the results, nonetheless, suggest that Wolbachia
infection of D. melanogaster does not inhibit infection by LACV.
Wolbachia inhibits WNV infection and reduces vector
competence in Cx. quinquefasciatus
Wolbachia that normally infect mosquito vectors of WNV are not
likely to inhibit viral infection to the same degree as seen in
Figure 2. Wolbachia-induced resistance to WNV infection in wild-type D. melanogaster strain BER1. The indicated pfu of WNV was injected
into Wolbachia(+) BER1 and Wolbachia(2) BER1-T strains of D. melanogaster. Seven days after inoculation, the titer of WNV in each fly was measured
by plaque assay. (A) The fraction of flies that became infected for each genotype at each concentration of virus, and the ID50 value for each genotype
as calculated from those data, are shown. (B) The titers of WNV in infected Wolbachia(+) BER1 (X) and Wolbachia(2) BER1-T flies (O) are shown. The
grey diagonal line indicates the amount of WNV inoculated per fly. The limit of detection of the plaque assay was 5 pfu/animal.
doi:10.1371/journal.pone.0011977.g002
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southern house mosquito Culex quinquefasciatus are widely, if not
universally, infected by Wolbachia, yet can be infected by and
transmit WNV in the lab, and are found infected by WNV in the
field, suggesting that Cx. quinquefasciatus is a natural vector of WNV
despite being infected by Wolbachia [44,45,46,47,48,49,50,51,52].
Nonetheless, we considered the possibility that Wolbachia might still
inhibit WNV infection in Cx. quinquefasciatus, but less than observed
in D. melanogaster.
A laboratory strain of Cx. quinquefasciatus infected with Wolbachia
was cured of Wolbachia infection by treatment with tetracycline. No
Wolbachia wsp gene sequences were detected in the mosquitoes
after treatment (Fig. 4). In addition, the loss of Wolbachia was
evidenced by the appearance of strong cytoplasmic incompatibil-
ity. Crosses between females from the treated Wolbachia(2) strain
and males from the original Wolbachia(+) strain were fully infertile,
while the reciprocal cross and crosses between Wolbachia(2)
individuals were fertile (data not shown). Finally, there was no
significant difference in the wet weight or wing length of newly
emerged females from the Wolbachia(+) and Wolbachia(2) strains,
suggesting that Wolbachia infection does not have a significant
effect on the growth of Cx. quinquefasciatus (data not shown).
To determine if Wolbachia infection of Cx. quinquefasciatus affects
susceptibility of the mosquitoes to WNV, we fed Wolbachia(+) and
Wolbachia(2) mosquitoes a blood meal containing WNV, and
determined the frequencies of infected mosquitoes, of virus
dissemination into the legs, and of virus transmission in the saliva
at 5, 7, and 14 days post blood meal (Table 1). Since all Cx.
quinquefasciatus mosquitoes are normally infected with Wolbachia,w e
were unable to test a naturally Wolbachia-free population of Cx.
quinquefasciatus for nonspecific affects of tetracycline treatment, as
was done for D. melanogaster (Fig. 3). Instead, we repeated the
experiment at five and fourteen generations after tetracycline
treatment, reasoning that any nonspecific phenotypes caused by
antibiotic toxicity would likely be transient and fail to persist for
more than a few generations. The Cx. quinquefasciatus colony
recovered rapidly after tetracycline treatment and was easily
expanded to normal numbers of animals within two generations
without any obvious reductions in fertility, fecundity, or viability.
At the relatively high titer of virus added to the blood meal,
most of both the Wolbachia(+) and Wolbachia(2) mosquitoes became
infected (Table 1). The frequency of infection of Wolbachia(+) and
Wolbachia(2) mosquitoes were similar even when the overall
frequency of infection was reduced by adding less virus to the
Figure 3. Tetracycline treatment of Wolbachia(2) Oregon R flies had little effect on susceptibility to WNV infection. The indicated pfu
of WNV was injected into untreated (OR) and tetracycline-treated (OR-T) Oregon R flies. Seven days after inoculation, the titer of WNV in each fly was
measured by plaque assay. (A) The fraction of flies that became infected for each genotype at each concentration of virus, and the ID50 value for each
genotype as calculated from those data, are shown. (B) The titers of WNV in untreated (X) and tetracycline-treated flies (O) are shown. The grey
diagonal line indicates the amount of WNV inoculated per fly. The limit of detection of the plaque assay was 25 pfu/animal.
doi:10.1371/journal.pone.0011977.g003
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temperatures (data not shown). In contrast to the similarity in
overall infection frequency, the frequencies of virus dissemination
into the legs and of virus transmission in the saliva were higher in
the Wolbachia(2) mosquitoes at all time points tested at both five
and fourteen generations (Table 1). The increase was between 2
and 3-fold at most time points. The fact that dissemination and
transmission rates for the Wolbachia(2) mosquitoes were higher at
all time points is highly significant (p,0.001; binomial probability),
and the fact that the same increases were observed both five and
fourteen generations after antibiotic treatment suggests that the
increased rates of WNV dissemination and transmission are a
permanent phenotypic consequence of removing Wolbachia from
Cx. quinquefasciatus mosquitoes rather than being a transient artifact
caused by antibiotic treatment.
Since the overall rate of infection did not differ between
Wolbachia(+) and Wolbachia(2) mosquitoes, it was unclear if the
increased rate of virus dissemination and transmission observed in
Wolbachia(2) mosquitoes was a consequence of increased suscep-
tibility of the mosquitoes to WNV infection (Table 1). To address
this question, we measured the titers of WNV in the bodies of all
the infected mosquitoes presented in Table 1 (Figure 6). While
virus titers varied widely in both the Wolbachia(+) and Wolbachia(2)
mosquitoes, the average titer was higher in Wolbachia(2)
mosquitoes at all time points tested (Figure 6). The higher average
titers in Wolbachia(2) mosquitoes, however, were only significant at
five generations, but not at fourteen generations after treatment
(p,0.00001 and p.0.05, respectively; ANOVA). More impor-
tantly, the probability of virus dissemination and transmission was
strongly correlated with virus titer in both the five generation and
fourteen generation experiments (p,0.0001; x
2 test). Infections
producing titers beyond a threshold of about 4.5 log10 pfu/
mosquito were likely to result in virus dissemination, and in
infections with the highest titers, virus transmission. This
correlation is particularly apparent when dissemination and
transmission status is compared with virus titer for each mosquito
(green and red pluses in Fig. 6). Most importantly, there was
clearly a greater proportion of Wolbachia(2) mosquitoes compared
to Wolbachia(+) mosquitoes having the highest virus titers at each
time point tested. The increase in the number of Wolbachia(2)
mosquitoes with the highest virus titers correlates with, and can
explain, the 2 to 3-fold higher rates of virus dissemination and
transmission observed for the Wolbachia(2) mosquitoes (cf. Fig. 6
and Table 1). These results support the conclusion that Wolbachia
normally inhibits WNV infection in Cx. quinquefasciatus mosquitoes,
limiting virus titers in infected animals and reducing the
probability that an infected mosquito will transmit virus during
feeding. Curing Cx. quinquefasciatus of Wolbachia infection, as
Figure 4. Wolbachia-induced resistance to CHIKV infection in D. melanogaster. The indicated pfu of CHIKV was injected into Wolbachia(+)
BER1 and Wolbachia(2) BER1-T flies. Seven days after inoculation, the titer of CHIKV in each fly was measured by plaque assay. (A) The fraction of flies
that became infected for each genotype at each concentration of virus, and the ID50 value for each genotype as calculated from those data, are
shown. (B) The titers of CHIKV in infected Wolbachia(+) BER1 (O) and Wolbachia(2) BER1-T flies (X) are shown. The grey diagonal line indicates the
amount of CHIKV inoculated per fly. The limit of detection of the plaque assay was 25 pfu/animal.
doi:10.1371/journal.pone.0011977.g004
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proportion of infected mosquitoes developing the high virus titers
necessary for virus dissemination and transmission.
Discussion
This is the first report of Wolbachia-induced resistance to
arbovirus infection in a native Wolbachia-mosquito system. While
the experiments reported here were done on a laboratory colony,
the results raise the possibility that Wolbachia infection could
impact vector competence of Cx. quinquefasciatus in the field. For
example, vector competence is known to vary between individuals
and between different populations of Cx. quinquefasciatus [49,50].
Similarly, Wolbachia infection densities can vary 100-fold between
individual field-collected Cx. pipiens, a closely related mosquito
species [53,54]. Furthermore, Wolbachia infection levels are
dynamic and can be sensitive to both environmental factors, such
as temperature, and host genetic factors that vary between
populations [54,55,56,57,58,59]. So, if the strength of Wolbachia-
induced viral resistance is sensitive to the differences in Wolbachia
levels that occur between mosquitoes, as some evidence suggests,
then vector competence in Cx. quinquefasciatus could potentially be
modulated indirectly through environmental and genetic factors
that modify levels of Wolbachia [39,60]. In addition to differences in
vector competence within a species, Wolbachia infection might also
contribute to differences in vector competence between species.
Figure 5. Wolbachia did not increase resistance to LACV infection in D. melanogaster. The indicated pfu of LACV was injected into
Wolbachia(+) BER1 and Wolbachia(2) BER1-T flies, and seven days after inoculation, the titer of LACV was measured in each fly by plaque assay. (A)
The fraction of flies that became infected for each genotype at each concentration of virus, and the ID50 value for each genotype as calculated from
those data, are shown. (B) The titers of LACV in infected Wolbachia(+) BER1 (O) and Wolbachia(2) BER1-T flies (X) are shown. The grey diagonal line
indicates the amount of CHIKV inoculated per fly. The limit of detection of the plaque assay was 10 pfu/animal.
doi:10.1371/journal.pone.0011977.g005
Table 1. Vector competence of untreated and tetracycline-treated Cx. quinquefasciatus.
5th generation after treatment 14th generation after treatment
dpm Wolbachia ID T I D T
5 + 23/25 (92)* 2/25 (8) 1/25 (4) 15/17 (88) 2/17 (12) 1/17 (6)
2 28/29 (97) 9/29 (31) 4/29 (14) 19/21 (90) 6/21 (29) 2/21 (10)
7 + 23/23 (100) 2/23 (9) 0/23 (0) 15/17 (88) 4/17 (24) 1/17 (6)
2 28/28 (100) 8/28 (29) 6/28 (21) 23/23 (100) 8/23 (35) 4/23 (17)
14 + 25/25 (100) 6/25 (24) 2/25 (8) 14/17 (82) 4/17 (24) 3/17 (18)
2 23/23 (100) 8/23 (35) 4/23 (17) 20/20 (100) 12/20 (60) 8/20 (40)
dpm, days post blood meal; I, infected body; D, disseminated to legs; T, transmitted to saliva.
*number of mosquitoes positive for virus/number assayed (percent).
doi:10.1371/journal.pone.0011977.t001
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is generally less susceptible to WNV infection than Culex tarsalis,
which is not infected with Wolbachia [50]. Our results suggest that
the difference in Wolbachia infection between these two species
could contribute, at least in part, to the observed difference in
vector competence.
Figure 6. Titers of WNV in infected Wolbachia(+) and Wolbachia(2) Cx. quinquefasciatus mosquitoes. Wolbachia(+) and Wolbachia(2) Cx.
quinquefasciatus mosquitoes were fed a blood meal containing WNV either five generations (A) or fourteen generations (B) after tetracycline
treatment. Titers of WNV in infected Wolbachia(+) mosquitoes (O) and in infected Wolbachia(2) mosquitoes (X) were measured by plaque assay 5, 7,
and 14 days post blood meal. The average virus titer is indicated by a horizontal line. Mosquitoes in which virus had disseminated only to the legs
(green) or that had disseminated to the legs and was transmitted in the saliva (red) are indicated by colored plus signs located next to the virus titer
for that same mosquito.
doi:10.1371/journal.pone.0011977.g006
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susceptibility and vector competence in other species of mosqui-
toes naturally infected by Wolbachia. Given that the strength of
Wolbachia-induced viral resistance in Drosophila is known to be
dependent on both virus type and Wolbachia strain, our observation
of Wolbachia-induced resistance to WNV in Cx. quinquefasciatus is
not necessarily applicable to other specific Wolbachia-mosquito-
arbovirus interactions [35,36,60]. In the one other mosquito
species in which Wolbachia-induced viral resistance has been
directly tested, Ae. albopictus, no increase in susceptibility to either
DENV or CHIKV infection was observed in mosquitoes cured of
Wolbachia, suggesting that the Wolbachia that normally infect Ae.
albopictus do not increase resistance to viral infection [40,41]. Even
this conclusion, however, may not be generally applicable to all Ae.
albopictus mosquitoes, since Wolbachia levels in somatic tissues can
vary significantly between different strains of Ae. albopictus, from
relatively abundant to undetectable, potentially impacting whether
a resistance phenotype is observed [59].
Wolbachia infection in Cx. quinquefasciatus inhibits the dissemina-
tion and transmission of WNV but not the overall frequency of
infection (Table 1). In the closely related species Culex pipiens,
Wolbachia levels are much lower in the midgut than in other
somatic tissues [59]. If Wolbachia is distributed the same way in Cx.
quinquefasciatus, then Wolbachia may not be present to inhibit
infection in the midgut epithelial cells where viral infection begins
(assuming that the mechanism of Wolbachia-induced resistance is
cell autonomous), resulting in the overall rate of viral infection
being independent of the presence or absence of Wolbachia. As the
WNV infection spread, however, the virus would encounter tissues
containing Wolbachia, and therefore more resistant to infection,
resulting in the lower virus titers and decreased rates of virus
dissemination and transmission that were observed. The degree of
overlap in the tissue distribution of Wolbachia and viral pathogen is
likely to be an important determinant in the extent to which
Wolbachia can inhibit vector competence in any given Wolbachia-
mosquito-arbovirus interaction [39]. Finally, Wolbachia-induced
resistance to WNV may be weaker in Cx. quinquefasciatus than in D.
melanogaster simply because levels of Wolbachia are lower in the
somatic tissues of Cx. quinquefasciatus than in D. melanogaster.
Preliminary comparison of Wolbachia levels in the two species is
consistent with that conclusion (unpublished observations).
There are at least eleven major supergroups of Wolbachia, and
until recently, all the Wolbachia strains shown to increase viral
resistance have been supergroup A strains that normally infect D.
melanogaster and D. simulans [35,36,39,60,61]. Recently, supergroup
B strain wAlbB from Ae. albopictus was shown to increase resistance
to DENV in the heterologous host Ae. aegypti [40]. This result does
not necessarily mean that supergroup B strains also induce viral
resistance in their native hosts, since host responses to Wolbachia
infection are know to differ between heterologous and native hosts.
For example, wAlbB induces the innate immune response in
heterologous host Ae. aegypti but not in native host Ae. albopictus
[40,62]. The wPip strain of Wolbachia infecting Cx. quinquefasciatus is
a supergroup B strain of Wolbachia, and the results reported here
are the first demonstration of viral resistance induced by a
supergroup B strain of Wolbachia in its native host [12,63]. The one
other study that has looked for viral resistance induced by a
supergroup B strain in its native host found that strain wNo
infecting D. simulans does not increase resistance against infection
by either DCV or FHV [60]. They also found, however, that levels
of wNo were significantly lower than the levels of three supergroup
A strains that also naturally infect D. simulans and that all increase
viral resistance [60]. Our observation of a Wolbachia-dependent
increase in viral resistance in Cx. quinquefasciatus demonstrates that
supergroup B strains of Wolbachia are capable of increasing
resistance to viral infection in their native hosts, and argues that
the absence of Wolbachia-induce resistance in wNo-infected D.
simulans is more likely due to low Wolbachia density than to an
intrinsic inability of supergroup B strains to confer a resistance
phenotype on their native hosts.
Recently, both D. melanogaster-derived wMelPop and Ae.
albopictus-derived wAlbB strains of Wolbachia when transferred into
Ae. aegypti have been shown to significantly increase resistance of
Ae. aegypti to DENV infection, with virus titers being suppressed
more than 10,000-fold in both cases [39,40]. This level of viral
resistance is comparable to the strong resistance phenotype
observed for WNV infection in D. melanogaster (Figs. 2, s5). The
fact that both WNV and DENV are especially sensitive to
Wolbachia-induced resistance in both native and heterologous
hosts, respectively, suggests that flaviviruses, in general, may be
particularly susceptible to Wolbachia-induced resistance and that
the mechanism of resistance to flavivirus infection is the same in
flies and mosquitoes. In contrast, the strength of Wolbachia-induced
resistance to infection by the alphavirus CHIKV differed markedly
between the same D. melanogaster and A. aegypti Wolbachia-host
systems. In D. melanogaster, Wolbachia-induced resistance to CHIKV
was modest and significantly lower than the resistance to WNV,
while in A. aegypti, resistance to CHIKV and to DENV were
equally strong (Fig. 4)[39]. The reason for the difference in the
relative susceptibility of CHIKV to Wolbachia-induced resistance is
not known, but likely arises from one of the differences between
the Wolbachia-host systems studied, which include the hosts (D.
melanogaster versus A. aegypti), the strains of Wolbachia (wMel versus
mosquito-adapted wMelPop), and the strains of virus (CHIKV
versus CHIKV
E1-A226V). Wolbachia-induced phenotypes, including
viral resistance, are known to be sensitive to differences in both
host species and Wolbachia strain [60,64,65].
The strength of Wolbachia-induced suppression of viral infection
in D. melanogaster varies widely amongst those viruses that have
been tested. Infections by WNV (Flaviviridae) and DCV (Dicistrovir-
idae) are both strongly suppressed, with virus titers being reduced at
least 10,000-fold for both viruses (this report)[35]. Infections by
CHIKV (Togaviridae) and NoraV virus (picorna-like family), in
contrast, are only modestly suppressed, with virus titers being
reduced about 10-fold, while infections by LACV (Bunyaviridae),
FHV (Nodaviridae) and IIV-6 (Iridoviridae) are unaffected (this
report)[35]. It is not clear why WNV and DCV are both so
selectively sensitive to Wolbachia-induced resistance. Although both
are positive-sense, ssRNA viruses, other positive-sense, ssRNA
viruses are less strongly affected (CHIKV, NoraV) or are not
affected at all at the level of virus replication (FHV). It is also
unclear whether negative-sense, ssRNA viruses like LACV and
dsDNA viruses like IIV-6 will, as a general rule, be refractory to
Wolbachia-induced resistance, given that only a single representa-
tive virus of either type has thus far been tested (this report)[35]. If
these results are representative, however, then Wolbachia-induce
resistance may be limited to a subset of positive-sense, ssRNA
viruses. An elucidation of virus specificity, particularly the marked
sensitivity shared by relatively dissimilar viruses like WNV and
DCV, will require a better understanding of the underlying
mechanism, or mechanisms, by which Wolbachia infection
increases viral resistance.
Finally, it is noteworthy that Wolbachia infection of D. melanogaster
inhibits WNV infection so dramatically without causing significant
deleterious effects to the host. Other than resistance to viral
infection, the particular Wolbachia-infected strains of D. melanogaster
studied here are unremarkable, with no obvious reductions in
viability, fertility, or fecundity (unpublished observations). Eluci-
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inhibits viral infection in D. melanogaster could, therefore, promote
the development of antiviral agents that either mimic the direct
antiviral action of Wolbachia proteins or modulate in therapeuti-
cally useful ways the same host pathways important for viral
infection. The complexity inherent in a biological system
comprising the interaction of three disparate organisms - bacterial
symbiont, insect host, and viral pathogen - presents significant
challenges for future mechanistic studies. Such studies will be
facilitated by the availability of extensive genetic and molecular
tools developed for D. melanogaster.
Materials and Methods
Insects and tetracycline treatment
D. melanogaster were maintained on cornmeal-brewer’s yeast-
glucose medium at 23uC and 45% relative humidity. Wild-type D.
melanogaster strains Oregon R and BER1 were obtained from the
Bloomington Drosophila Stock Center. AGO2
414 flies were
obtained from Haruhiko Siomi [66]. Flies were cured of Wolbachia
infection by growing the flies for one generation on instant food
(Carolina Biological) made with 200 mg/ml tetracycline. Removal
of the Wolbachia was confirmed by PCR.
Cx. quinquefasciatus were maintained at 26uC, 50% RH with a
16:8 L:D photoperiod. Larvae were reared at 300 larvae/liter with
a water depth of 1.5 cm and fed standardized volumes of ground
koi pellets. Adults were maintained on 10% sucrose ad libitum and
fed goose blood supplemented with 2.5% sucrose for egg laying.
The Wolbachia(+) Cx. quinquefasciatus colony was established from
mosquitoes obtained from Benzon Research, Inc. (Carlisle, PA),
who established their colony in 1995 from a preexisting colony
maintained at that time at Virginia Polytechnic Institute and State
University. Mosquitoes were cured of Wolbachia infection by
feeding adults for one week on 1 mg/ml tetracycline (pH 7) in
10% sucrose [67]. Mosquitoes were then fed a blood meal and
maintained for one week on 10% sucrose without tetracycline
before collecting eggs, followed by a second blood meal and
subsequent egg collection. Mosquitoes produced from both blood
meals were pooled, and used to start the Wolbachia(2) strain.
Removal of the Wolbachia was confirmed by PCR.
PCR
Total DNA was isolated from five pools of five animals each
pool for D. melanogaster and ten pools of two animals each pool for
Cx. quinquefasciatus (Gentra, Qiagen). The presence of Wolbachia wsp
gene sequences and mitochondrial 12S rRNA gene sequences was
determined in each extract by PCR. Primers 81F and 691R were
used for the wsp gene, and primers 12Sai and 12Sbi were used for
the 12S gene, both as described previously [12,68].
Viruses
The WNV stock was derived from WNV NY003356, a primary
isolate from kidney tissue of an American crow collected in 2000 in
Staten Island, NY [69]. The virus stock was prepared by three
rounds of plaque purification in Vero cells. The CHIKV stock was
derived from human isolate HIMTSSA 287 originally collected in
the Central African Republic in 1995 and maintained at the
Centers for Disease Control and Prevention, Fort Collins, CO.
The virus was passaged three times in Vero cells before stock
preparation. The LACV stock was likely derived from mosquito
pool 74-32813 collected from New York state in 1974 and
maintained at the Wadsworth Center, New York State Depart-
ment of Health, Albany, NY. The virus was passaged once in
BHK cells, and twice in Vero cells before stock preparation. All
experiments involving infectious WNV, CHIKV, or LACV were
done in the Wadsworth Center’s ACL-3 laboratories.
Virus Inoculation into D. melanogaster
D. melanogaster were inoculated essentially as described previ-
ously [42]. Briefly, female flies 3–5 days old were anesthetized on
ice and injected intra-abdominally with ,100 nl of Dulbecco’s
modified Eagle medium containing virus at the selected concen-
tration. The injection volume was controlled with a pneumatic
injector. Flies being compared within any single experiment were
always injected during the same injection session, using the same
injector settings and reagents, and the inoculated flies were
incubated together at 27uC, 55% RH with a 16:8 L:D photoperiod
for 7 days before being harvested for analysis of virus titer.
Individual flies were placed into 0.5 mL mosquito diluent (MD:
Dulbecco’s phosphate-buffered saline supplemented with 20%
fetal bovine serum (FBS), 50 mg/ml penicillin, 50 mg/ml strepto-
mycin, 50 mg/ml gentamicin, 2.5 mg/ml Fungizone), homoge-
nized using a mixer mill, and stored at 270uC until virus titers
were measured by plaque assay.
Vector competence of Cx. quinquefasciatus
Vector competence assays were performed essentially as
described previously [70]. Briefly, 5–7 day old females were fed
a blood meal of goose blood supplemented with 2.5% sucrose plus
WNV at a final titer of 4610
8 pfu/mL. Mosquitoes were fed for
1 hourr using a Hemotek membrane feeder (Discovery Work-
shops, Accrington, UK). Virus titer in the blood meal did not
change during the course of the 1 hour feeding. Fully engorged
mosquitoes were sorted into pint cartons supplied with 10%
sucrose ad libitum and held at 27uC, 55% RH, and 16:8 L:D
photoperiod before being assayed. At 5, 7, and 14 days post blood
meal, mosquitoes were anesthetized with triethylamine, and their
legs were removed and placed into 0.5 mL MD. Saliva was
collected by placing the proboscis into a capillary tube containing
50% FBS, 50% sucrose for 30 minutes, and then the solution in
the capillary was dispensed into 0.5 mL MD. The body was placed
into 0.5 mL MD, and the body and legs were homogenized by
mixer mill. Samples were stored at 270uC until the proportion of
mosquitoes with infected bodies (infected), infected legs (dissem-
inated), and infected saliva (transmitted) was determined by plaque
assay. Results obtained for the Wolbachia(+) and Wolbachia(2)
strains of Cx. quinquefasciatus were compared using binomial
probability analysis.
Plaque Assays
Vero cell plaque assays were used to determine titers of WNV,
CHIKV, and LACV essentially as described previously [71]. Virus
titers in different strains of D. melanogaster were compared using
Student’s t-tests, and ID50 values were calculated using program
ID50 5.0 [72]. Virus titers in Wolbachia(+) and Wolbachia(2) Cx.
quinquefasciatus were compared using ANOVA analysis after
confirming the data were normally distributed using the
Anderson-Darling test statistic. Correlation of the probability of
virus dissemination into the legs and of virus transmission into the
saliva with virus titer measured in the bodies of Wolbachia(+) and
Wolbachia(2) Cx. quinquefasciatus was done using x
2 analysis.
Supporting Information
Text S1 Supplemental data for figures S1-S5.
Found at: doi:10.1371/journal.pone.0011977.s001 (0.04 MB
DOC)
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414 differ in
their susceptibility to WNV infection. The indicated pfu of WNV
was injected into D. melanogaster strains wild-type Oregon R (OR)
and Ago2
414 (414). Seven days after inoculation, the titer of WNV
in each fly was measured by plaque assay. (A) The fraction of flies
that became infected for each genotype at each concentration of
virus, and the ID50 value for each genotype as calculated from
those data, are shown. (B) The titers of WNV in the infected OR
(O) and 414 flies (X) are shown. The grey diagonal line indicates
the amount of WNV inoculated per fly. The limit of detection of
the plaque assay was 25 pfu/animal for strain OR and 2.5 pfu/
animal for strain 414.
Found at: doi:10.1371/journal.pone.0011977.s002 (0.07 MB
PDF)
Figure S2 The WNV resistance phenotype observed in Ago2
414
flies is a dominant maternal-effect phenotype. The indicated pfu of
WNV was injected into progeny from the reciprocal crosses female
OR x male 414 (MAT-OR) and female 414 x male OR (MAT-
414). Seven days after inoculation, the titer of WNV in each fly
was measured by plaque assay. (A) The fraction of flies that
became infected for each genotype at each concentration of virus,
and the ID50 value for each genotype as calculated from those
data, are shown. (B) The titers of WNV in the infected MAT-OR
(O) and MAT-414 flies (X) are shown. The grey diagonal line
indicates the amount of WNV inoculated per fly. The limit of
detection of the plaque assay was 25 pfu/animal for MAT-OR
and 2.5 pfu/animal for MAT-414.
Found at: doi:10.1371/journal.pone.0011977.s003 (0.06 MB
PDF)
Figure S3 The WNV resistance phenotype observed in Ago2
414
flies is caused by a maternal cytoplasmic factor. Twenty three pfu
of WNV was injected into female progeny from each generation of
five consecutive introgression backcrosses of female progeny to
OR males, starting with the cross of resistant strain 414 females to
susceptible OR males. As a positive control at each generation,
WNV was also injected into females from the OR stock, and the
inoculated females were assayed in parallel with the female
progeny from the introgression backcrosses. Seven days after
inoculation, the titer of WNV was measured by plaque assay in the
backcross progeny flies (X) and control OR flies (O). The ratio of
the number of flies infected to the number of flies inoculated for
each generation is shown along the top of the graph for the OR
control flies and along the bottom of the graph for the backcross
progeny flies. The limit of detection of the plaque assay was
25 pfu/animal and is shown by a dashed grey line.
Found at: doi:10.1371/journal.pone.0011977.s004 (0.04 MB
PDF)
Figure S4 The Wolbachia status of D. melanogaster strains analyzed
for susceptibility to arbovirus infection. DNA was isolated from D.
melanogaster strains Oregon R (OR), Ago2
414 (414) and tetracycline-
treated Ago2
414 (414-T). DNA sequences corresponding to the wsp
gene of Wolbachia and the 12S mitochondrial gene were identified
by PCR.
Found at: doi:10.1371/journal.pone.0011977.s005 (0.09 MB
PDF)
Figure S5 The WNV resistance phenotype observed in Ago2
414
flies was lost after tetracycline treatment. The indicated pfu of
WNV was injected into D. melanogaster strain Ago2
414 (414) and
tetracycline-treated Ago2
414 (414-T). Seven days after inoculation,
the titer of WNV in each fly was measured by plaque assay. (A)
The fraction of flies that became infected for each genotype at
each concentration of virus, and the ID50 value for each genotype
as calculated from those data, are shown. (B) The titers of WNV in
the infected 414 (X) and 414-T flies (O) are shown. The grey
diagonal line indicates the amount of WNV inoculated per fly.
The limit of detection of the plaque assay was 5 pfu/animal.
Found at: doi:10.1371/journal.pone.0011977.s006 (0.06 MB
PDF)
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